Improving the solubility and pharmacological efficacy of curcumin by heat treatment - PubMed (original) (raw)
Improving the solubility and pharmacological efficacy of curcumin by heat treatment
Biji T Kurien et al. Assay Drug Dev Technol. 2007 Aug.
Abstract
Lipid peroxidation has been implicated in a variety of diseases. 4-Hydroxy-2-nonenal (HNE), a major oxidation by-product, is cytotoxic, mutagenic, and genotoxic, being involved in disease pathogenesis. Naturally occurring pharmacologically active small molecules are very attractive as natural nonsteroidal anti-inflammatory agents. Interest has greatly increased recently in the pharmacotherapeutic potential of curcumin, the yellow pigment found in the rhizomes of the perennial herb Curcuma longa (turmeric). Curcumin is efficacious against colon cancer, cystic fibrosis, and a variety of other disorders. Curcumin's full pharmacological potential is limited owing to its extremely limited water solubility. We report here that the water solubility of curcumin could be increased from 0.6 microg/ml to 7.4 microg/ml (12-fold increase) by the use of heat. Spectrophotometric (400-700 nm) and mass spectrometric profiling of the heat-extracted curcumin displays no significant heat-mediated disintegration of curcumin. Using an enzyme-linked immunosorbent assay that employed HNE modification of solid-phase antigen, we found that the heat-solubilized curcumin inhibited HNE-protein modification by 80%. Thus, inhibition of HNE modification may be a mechanism by which curcumin exerts its effect. We also report a simple assay to detect curcumin spectrophotometrically. Curcumin was solubilized in methanol and serially diluted in methanol to obtain a set of standards that were then read for optical density at 405 nm. Curcumin in the heat-solubilized samples was determined from this standard. Heat-solubilized curcumin should be considered in clinical trials involving curcumin, especially in the face of frustrating results obtained regarding curcumin-mediated correction of cystic fibrosis defects.
Comment in
- A Kinetic Degradation Study of Curcumin in Its Free Form and Loaded in Polymeric Micelles.
Naksuriya O, van Steenbergen MJ, Torano JS, Okonogi S, Hennink WE. Naksuriya O, et al. AAPS J. 2016 May;18(3):777-87. doi: 10.1208/s12248-015-9863-0. Epub 2016 Apr 1. AAPS J. 2016. PMID: 27038456 Free PMC article.
Similar articles
- Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification--an in vitro study.
Kurien BT, Scofield RH. Kurien BT, et al. J Ethnopharmacol. 2007 Mar 21;110(2):368-73. doi: 10.1016/j.jep.2006.09.034. Epub 2006 Oct 13. J Ethnopharmacol. 2007. PMID: 17116380 - Heat-solubilized curry spice curcumin inhibits antibody-antigen interaction in in vitro studies: a possible therapy to alleviate autoimmune disorders.
Kurien BT, D'Souza A, Scofield RH. Kurien BT, et al. Mol Nutr Food Res. 2010 Aug;54(8):1202-9. doi: 10.1002/mnfr.200900106. Mol Nutr Food Res. 2010. PMID: 20146265 Free PMC article. - Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress.
Martinez-Cifuentes M, Weiss-Lopez B, Santos LS, Araya-Maturana R. Martinez-Cifuentes M, et al. Curr Top Med Chem. 2015;15(17):1663-72. doi: 10.2174/1568026615666150427111837. Curr Top Med Chem. 2015. PMID: 25915614 Review. - Curcumin/Turmeric as an Environment-Friendly Protein Gel Stain.
Kurien BT, Dorri Y, Scofield RH. Kurien BT, et al. Methods Mol Biol. 2018;1853:121-131. doi: 10.1007/978-1-4939-8745-0_15. Methods Mol Biol. 2018. PMID: 30097937 - Curcumin: from chemistry to chemistry-based functions.
Jitoe-Masuda A, Fujimoto A, Masuda T. Jitoe-Masuda A, et al. Curr Pharm Des. 2013;19(11):2084-92. Curr Pharm Des. 2013. PMID: 23116314 Review.
Cited by
- Treatment of colitis by oral negatively charged nanostructured curcumin in rats.
Celani LMS, Egito EST, Azevedo ÍM, Oliveira CN, Dourado D, Medeiros AC. Celani LMS, et al. Acta Cir Bras. 2022 Aug 15;37(6):e370602. doi: 10.1590/acb370602. eCollection 2022. Acta Cir Bras. 2022. PMID: 35976279 Free PMC article. - Therapeutic potential of curcumin and curcumin analogues in rheumatology.
Kurien BT, Danda D, Scofield RH. Kurien BT, et al. Int J Rheum Dis. 2015 Jul;18(6):591-3. doi: 10.1111/1756-185X.12753. Int J Rheum Dis. 2015. PMID: 26301972 Free PMC article. No abstract available. - Simultaneous Delivery of Curcumin and Resveratrol via In Situ Gelling, Raft-Forming, Gastroretentive Formulations.
Siripruekpong W, Praparatana R, Issarachot O, Wiwattanapatapee R. Siripruekpong W, et al. Pharmaceutics. 2024 May 10;16(5):641. doi: 10.3390/pharmaceutics16050641. Pharmaceutics. 2024. PMID: 38794303 Free PMC article. - Curcumin Nanoformulations with Metal Oxide Nanomaterials for Biomedical Applications.
Beyene AM, Moniruzzaman M, Karthikeyan A, Min T. Beyene AM, et al. Nanomaterials (Basel). 2021 Feb 11;11(2):460. doi: 10.3390/nano11020460. Nanomaterials (Basel). 2021. PMID: 33670161 Free PMC article. Review. - Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management.
Henrotin Y, Priem F, Mobasheri A. Henrotin Y, et al. Springerplus. 2013 Dec;2(1):56. doi: 10.1186/2193-1801-2-56. Epub 2013 Feb 18. Springerplus. 2013. PMID: 23487030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical